Financials
- Market Capitalization 65.03 M
- Employee 78
- Founded 2006
- CEO Lindsay Rosenwald
- Website www.fortressbiotech.com
- Headquarter Delaware, United States
- FIGI BBG001J2MFH6
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-52.29
Rapporto prezzo/fatturato
1.61
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4042 | SPRO Spero Therapeutics, Inc. - Common Stock | 1.15 USD | -2.54% | -3.36% | +0.88% | -52.08% | 66.97 M USD | ||
| 4047 | XBIT XBiotech Inc. - Common Stock | 2.16 USD | -4.85% | 0.00% | 0.00% | -14.29% | 65.85 M USD | ||
| 4056 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.75 USD | -3.85% | -6.25% | -3.85% | -31.84% | 64.70 M USD | ||
| 4063 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.49 USD | +4.26% | -16.95% | -40.96% | -59.17% | 62.48 M USD |